title: Should glucose-sparing prescriptions be expected to reduce the cardiovascular risk of peritoneal dialysis patients?
authors.affiliation: Kidney Research Institute and Division of Nephrology, University of Washington, Seattle, Washington.
authors.forename: Rajnish
authors.initials: R
authors.lastname: Mehrotra
authors.forename: Ian H
authors.initials: IH
authors.lastname: de Boer
mesh_terms: D003928:Diabetic Nephropathies / Q000628:therapy*; D005260:Female; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D010530:Peritoneal Dialysis / Q000379:methods*
chemical_list: D005947:Glucose